1887

Abstract

Contemporary influenza B virus strains were generated encoding C-terminally truncated NS1 proteins. Viable viruses containing the N-terminal 14, 38, 57 or 80 aa of the NS1 protein were rescued in Vero cells. The influenza B virus NS1-truncated mutants were impaired in their ability to counteract interferon (IFN) production, induce antiviral pro-inflammatory cytokines early after infection and show attenuated or restricted growth in IFN-competent hosts. In Vero cells, all of the mutant viruses replicated to high titres comparable to the wild-type influenza B virus. Mice that received a single, intranasal immunization of the NS1-truncated mutants elicited an antibody response and protection against wild-type virus challenge. Therefore, these NS1-truncated mutants should prove useful as potential candidates for live-attenuated influenza virus vaccines.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.006122-0
2009-02-01
2019-11-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/2/366.html?itemId=/content/journal/jgv/10.1099/vir.0.006122-0&mimeType=html&fmt=ahah

References

  1. Chen, W., Calvo, P. A., Malide, D., Gibbs, J., Schubert, U., Bacik, I., Basta, S., O'Neill, R., Schickli, J. & other authors ( 2001; ). A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7, 1306–1312.[CrossRef]
    [Google Scholar]
  2. Dauber, B., Heins, G. & Wolff, T. ( 2004; ). The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction. J Virol 78, 1865–1872.[CrossRef]
    [Google Scholar]
  3. Dauber, B., Schneider, J. & Wolff, T. ( 2006; ). Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon. J Virol 80, 11667–11677.[CrossRef]
    [Google Scholar]
  4. Dittmann, J., Stertz, S., Grimm, D., Steel, J., García-Sastre, A., Haller, O. & Kochs, G. ( 2008; ). Influenza A virus strains differ in sensitivity to the antiviral action of the Mx-GTPase. J Virol 82, 3624–3631.[CrossRef]
    [Google Scholar]
  5. Donelan, N. R., Basler, C. F. & García-Sastre, A. ( 2003; ). A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 77, 13257–13266.[CrossRef]
    [Google Scholar]
  6. Donelan, N. R., Dauber, B., Wang, X., Basler, C. F., Wolff, T. & García-Sastre, A. ( 2004; ). The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation. J Virol 78, 11574–11582.[CrossRef]
    [Google Scholar]
  7. Du, W. & Maniatis, T. ( 1992; ). An ATF/CREB binding site is required for virus induction of the human interferon beta gene [corrected]. Proc Natl Acad Sci U S A 89, 2150–2154.[CrossRef]
    [Google Scholar]
  8. Egorov, A., Brandt, S., Sereinig, S., Romanova, J., Ferko, B., Katinger, D., Grassauer, A., Alexandrova, G., Katinger, H. & Muster, T. ( 1998; ). Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J Virol 72, 6437–6441.
    [Google Scholar]
  9. Ferko, B., Stasakova, J., Romanova, J., Kittel, C., Sereinig, S., Katinger, H. & Egorov, A. ( 2004; ). Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J Virol 78, 13037–13045.[CrossRef]
    [Google Scholar]
  10. Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S. M. & Maniatis, T. ( 2003; ). IKKϵ and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4, 491–496.
    [Google Scholar]
  11. García-Sastre, A. & Biron, C. A. ( 2006; ). Type 1 interferons and the virus–host relationship: a lesson in détente. Science 312, 879–882.[CrossRef]
    [Google Scholar]
  12. García-Sastre, A., Egorov, A., Matassov, D., Brandt, S., Levy, D. E., Durbin, J. E., Palese, P. & Muster, T. ( 1998; ). Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252, 324–330.[CrossRef]
    [Google Scholar]
  13. Hoffmann, E., Krauss, S., Perez, D., Webby, R. & Webster, R. G. ( 2002; ). Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20, 3165–3170.[CrossRef]
    [Google Scholar]
  14. Holzinger, D., Jorns, C., Stertz, S., Boisson-Dupuis, S., Thimme, R., Weidmann, M., Casanova, J. L., Haller, O. & Kochs, G. ( 2007; ). Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol 81, 7776–7785.[CrossRef]
    [Google Scholar]
  15. Imai, M., Kawasaki, K. & Odagiri, T. ( 2008; ). Cytoplasmic domain of influenza B virus BM2 protein plays critical roles in production of infectious virus. J Virol 82, 728–739.[CrossRef]
    [Google Scholar]
  16. Juang, Y. T., Lowther, W., Kellum, M., Au, W. C., Lin, R., Hiscott, J. & Pitha, P. M. ( 1998; ). Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc Natl Acad Sci U S A 95, 9837–9842.[CrossRef]
    [Google Scholar]
  17. Julkunen, I., Sareneva, T., Pirhonen, J., Ronni, T., Melen, K. & Matikainen, S. ( 2001; ). Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 12, 171–180.[CrossRef]
    [Google Scholar]
  18. Kaufmann, A., Salentin, R., Meyer, R. G., Bussfeld, D., Pauligk, C., Fesq, H., Hofmann, P., Nain, M., Gemsa, D. & Sprenger, H. ( 2001; ). Defense against influenza A virus infection: essential role of the chemokine system. Immunobiology 204, 603–613.[CrossRef]
    [Google Scholar]
  19. Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O. & Akira, S. ( 2005; ). IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6, 981–988.[CrossRef]
    [Google Scholar]
  20. Kim, M. J., Latham, A. G. & Krug, R. M. ( 2002; ). Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc Natl Acad Sci U S A 99, 10096–10101.[CrossRef]
    [Google Scholar]
  21. Kittel, C., Ferko, B., Kurz, M., Voglauer, R., Sereinig, S., Romanova, J., Stiegler, G., Katinger, H. & Egorov, A. ( 2005; ). Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment. J Virol 79, 10672–10677.[CrossRef]
    [Google Scholar]
  22. Lenschow, D. J., Lai, C., Frias-Staheli, N., Giannakopoulos, N. V., Lutz, A., Wolff, T., Osiak, A., Levine, B., Schmidt, R. E. & other authors ( 2007; ). IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104, 1371–1376.[CrossRef]
    [Google Scholar]
  23. Levy, D. E., Marie, I., Smith, E. & Prakash, A. ( 2002; ). Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback. J Interferon Cytokine Res 22, 87–93.[CrossRef]
    [Google Scholar]
  24. Lin, R., Heylbroeck, C., Pitha, P. M. & Hiscott, J. ( 1998; ). Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18, 2986–2996.
    [Google Scholar]
  25. Lu, Y., Qian, X. Y. & Krug, R. M. ( 1994; ). The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev 8, 1817–1828.[CrossRef]
    [Google Scholar]
  26. Lu, Y., Wambach, M., Katze, M. G. & Krug, R. M. ( 1995; ). Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214, 222–228.[CrossRef]
    [Google Scholar]
  27. Ludwig, S., Wang, X., Ehrhardt, C., Zheng, H., Donelan, N., Planz, O., Pleschka, S., García-Sastre, A., Heins, G. & Wolff, T. ( 2002; ). The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol 76, 11166–11171.[CrossRef]
    [Google Scholar]
  28. Ludwig, S., Pleschka, S., Planz, O. & Wolff, T. ( 2006; ). Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell Microbiol 8, 375–386.[CrossRef]
    [Google Scholar]
  29. Marion, R. M., Zurcher, T., de la Luna, S. & Ortin, J. ( 1997; ). Influenza virus NS1 protein interacts with viral transcription–replication complexes in vivo. J Gen Virol 78, 2447–2451.
    [Google Scholar]
  30. Matikainen, S., Pirhonen, J., Miettinen, M., Lehtonen, A., Govenius-Vintola, C., Sareneva, T. & Julkunen, I. ( 2000; ). Influenza A and Sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. Virology 276, 138–147.[CrossRef]
    [Google Scholar]
  31. McWhirter, S. M., Fitzgerald, K. A., Rosains, J., Rowe, D. C., Golenbock, D. T. & Maniatis, T. ( 2004; ). IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci U S A 101, 233–238.[CrossRef]
    [Google Scholar]
  32. Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R. & Tschopp, J. ( 2005; ). Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167–1172.[CrossRef]
    [Google Scholar]
  33. Min, J. Y. & Krug, R. M. ( 2006; ). The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A 103, 7100–7105.[CrossRef]
    [Google Scholar]
  34. Nemeroff, M. E., Barabino, S. M., Li, Y., Keller, W. & Krug, R. M. ( 1998; ). Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′ end formation of cellular pre-mRNAs. Mol Cell 1, 991–1000.[CrossRef]
    [Google Scholar]
  35. Palese, P., Muster, T., Zheng, H., O'Neill, R. & García-Sastre, A. ( 1999; ). Learning from our foes: a novel vaccine concept for influenza virus. Arch Virol Suppl 15, 131–138.
    [Google Scholar]
  36. Peters, K. L., Smith, H. L., Stark, G. R. & Sen, G. C. ( 2002; ). IRF-3-dependent, NFκB- and JNK-independent activation of the 561 and IFN-β genes in response to double-stranded RNA. Proc Natl Acad Sci U S A 99, 6322–6327.[CrossRef]
    [Google Scholar]
  37. Pichlmair, A., Schulz, O., Tan, C. P., Naslund, T. I., Liljestrom, P., Weber, F. & Reis e Sousa, C. ( 2006; ). RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314, 997–1001.[CrossRef]
    [Google Scholar]
  38. Proietti, E., Bracci, L., Puzelli, S., Di Pucchio, T., Sestili, P., De Vincenzi, E., Venditti, M., Capone, I., Seif, I. & other authors ( 2002; ). Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model. J Immunol 169, 375–383.[CrossRef]
    [Google Scholar]
  39. Qiu, Y. & Krug, R. M. ( 1994; ). The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J Virol 68, 2425–2432.
    [Google Scholar]
  40. Reed, R. & Cheng, H. ( 2005; ). TREX, SR proteins and export of mRNA. Curr Opin Cell Biol 17, 269–273.[CrossRef]
    [Google Scholar]
  41. Samuel, C. E. ( 2001; ). Antiviral actions of interferons. Clin Microbiol Rev 14, 778–809.[CrossRef]
    [Google Scholar]
  42. Sato, M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T., Katsuki, M., Noguchi, S. & other authors ( 2000; ). Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity 13, 539–548.[CrossRef]
    [Google Scholar]
  43. Seth, R. B., Sun, L., Ea, C. K. & Chen, Z. J. ( 2005; ). Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF 3. Cell 122, 669–682.[CrossRef]
    [Google Scholar]
  44. Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G. P., Lin, R. & Hiscott, J. ( 2003; ). Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148–1151.[CrossRef]
    [Google Scholar]
  45. Shaw, M. W., Choppin, P. W. & Lamb, R. A. ( 1983; ). A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase. Proc Natl Acad Sci U S A 80, 4879–4883.[CrossRef]
    [Google Scholar]
  46. Shimizu, K., Handa, H., Nakada, S. & Nagata, K. ( 1994; ). Regulation of influenza virus RNA polymerase activity by cellular and viral factors. Nucleic Acids Res 22, 5047–5053.[CrossRef]
    [Google Scholar]
  47. Stasakova, J., Ferko, B., Kittel, C., Sereinig, S., Romanova, J., Katinger, H. & Egorov, A. ( 2005; ). Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1β and 18. J Gen Virol 86, 185–195.[CrossRef]
    [Google Scholar]
  48. Talon, J., Horvath, C. M., Polley, R., Basler, C. F., Muster, T., Palese, P. & García-Sastre, A. ( 2000a; ). Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74, 7989–7996.[CrossRef]
    [Google Scholar]
  49. Talon, J., Salvatore, M., O'Neill, R. E., Nakaya, Y., Zheng, H., Muster, T., García-Sastre, A. & Palese, P. ( 2000b; ). Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc Natl Acad Sci U S A 97, 4309–4314.[CrossRef]
    [Google Scholar]
  50. Tovey, M. G., Lallemand, C. & Thyphronitis, G. ( 2008; ). Adjuvant activity of type I interferons. Biol Chem 389, 541–545.
    [Google Scholar]
  51. Wang, W. & Krug, R. M. ( 1996; ). The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. Virology 223, 41–50.[CrossRef]
    [Google Scholar]
  52. Wang, X., Li, M., Zheng, H., Muster, T., Palese, P., Beg, A. A. & García-Sastre, A. ( 2000; ). Influenza A virus NS1 protein prevents activation of NF-κB and induction of alpha/beta interferon. J Virol 74, 11566–11573.[CrossRef]
    [Google Scholar]
  53. Wathelet, M. G., Lin, C. H., Parekh, B. S., Ronco, L. V., Howley, P. M. & Maniatis, T. ( 1998; ). Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol Cell 1, 507–518.[CrossRef]
    [Google Scholar]
  54. Weaver, B. K., Kumar, K. P. & Reich, N. C. ( 1998; ). Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol Cell Biol 18, 1359–1368.
    [Google Scholar]
  55. Wolff, T., O'Neill, R. E. & Palese, P. ( 1996; ). Interaction cloning of NS1-I, a human protein that binds to the nonstructural NS1 proteins of influenza A and B viruses. J Virol 70, 5363–5372.
    [Google Scholar]
  56. Wolff, T., O'Neill, R. E. & Palese, P. ( 1998; ). NS1-binding protein (NS1-BP): a novel human protein that interacts with the influenza A virus nonstructural NS1 protein is relocalized in the nuclei of infected cells. J Virol 72, 7170–7180.
    [Google Scholar]
  57. Wright, P. F. & Webster, R. G. ( 2001; ). Orthomyxoviruses. In Fields Virology, 4th edn, pp. 1533–1579. Edited by B. N. Fields & D. M. Knipe. Philadelphia, PA: Lippincott Williams & Wilkins.
  58. Xu, L. G., Wang, Y. Y., Han, K. J., Li, L. Y., Zhai, Z. & Shu, H. B. ( 2005; ). VISA is an adapter protein required for virus-triggered IFN-β signaling. Mol Cell 19, 727–740.[CrossRef]
    [Google Scholar]
  59. Yoneyama, M., Suhara, W., Fukuhara, Y., Fukuda, M., Nishida, E. & Fujita, T. ( 1998; ). Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J 17, 1087–1095.[CrossRef]
    [Google Scholar]
  60. Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S. & Fujita, T. ( 2004; ). The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5, 730–737.[CrossRef]
    [Google Scholar]
  61. Yuan, W. & Krug, R. M. ( 2001; ). Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 20, 362–371.[CrossRef]
    [Google Scholar]
  62. Yuan, W., Aramini, J. M., Montelione, G. T. & Krug, R. M. ( 2002; ). Structural basis for ubiquitin-like ISG 15 protein binding to the NS1 protein of influenza B virus: a protein–protein interaction function that is not shared by the corresponding N-terminal domain of the NS1 protein of influenza A virus. Virology 304, 291–301.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.006122-0
Loading
/content/journal/jgv/10.1099/vir.0.006122-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error